Xcout Intel
Plastomics Inc.
Plastomics Inc. is an early-stage plant biotechnology company based in St. Louis, Missouri, developing next-generation trait delivery technology through a novel chloroplast system to create safer and more effective crops.
Subscribe to see Plastomics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Plastomics Inc. at a glance
Plastomics Inc. is a biotechnology company headquartered in United States. Its most recent funding round, Seed, raised $5.8M in October 2025. Xcout tracks 1 named person at Plastomics Inc., including Charlie Bolten (Chairman of the Board).
Plastomics Inc. leadership
- Charlie BoltenChairman of the Board
Plastomics Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $5.8M | 14 named | |
| — | $7.1M | 6 named | |
| SEC Form D filing | $3.2M | — | |
| SEC Form D filing | $2.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Plastomics Inc. competitors
A few of Plastomics Inc.'s closest competitors — see the full list of competitors and alternatives →
Omniose is an early-stage biotechnology and life sciences company headquartered in Saint Louis, Missouri. The firm develops polysaccharide conjugate vaccines against serious bacterial threats using its proprietary technology.
Prolific Machines Inc. is a U.S. biotechnology company developing biomanufacturing technology for producing cultivated meat and other cell-based products. Its platform is intended to help food and biotechnology companies manufacture these products more efficiently and at commercial scale.
ImmunoPhotonics, Inc. is a privately owned clinical-stage biopharmaceutical and pharmaceutical manufacturing company located in St. Louis, Missouri, specializing in interventional immuno-oncology.
Cadre Bioscience is a biopharmaceutical company headquartered in St. Louis, Missouri. The company employs a lean business model to accelerate the development of multiple diverse early-stage therapeutic assets.
Get Plastomics Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Plastomics Inc. in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access